Literature DB >> 24531224

Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.

Xun Ji1, Mingbo Su2, Jiang Wang3, Guanghui Deng3, Sisi Deng3, Zeng Li3, Chunlan Tang3, Jingya Li3, Jia Li4, Linxiang Zhao5, Hualiang Jiang1, Hong Liu6.   

Abstract

A series of novel hetero-aromatic moieties substituted α-amino pyrrole-2-carbonitrile derivatives was designed and synthesized based on structure-activity relationships (SARs) of pyrrole-2-carbonitrile inhibitors. All compounds demonstrated good dipeptidyl peptidase IV (DPP4) inhibitory activities (IC50 = 0.004-113.6 μM). Moreover, compounds 6h (IC50 = 0.004 μM) and 6n (IC50 = 0.01 μM) showed excellent inhibitory activities against DPP4, good selectivity (compound 6h, selective ratio: DPP8/DPP4 = 450.0; DPP9/DPP4 = 375.0; compound 6n, selective ratio: DPP8/DPP4 = 470.0; DPP9/DPP4 = 750.0) and good efficacy in an oral glucose tolerance test in ICR mice. Furthermore, compounds 6h and 6n demonstrated moderate PK properties (compound 6h, F% = 37.8%, t1/2 = 1.45 h; compound 6n, F% = 16.8%, t1/2 = 3.64 h).
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  DPP4 inhibitors; Oral bioavailability; Oral glucose tolerance test; Reversible kinetic characterization; Selectivity

Mesh:

Substances:

Year:  2014        PMID: 24531224     DOI: 10.1016/j.ejmech.2014.01.021

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 Inhibitors.

Authors:  Tao Jiang; Yuren Zhou; Zhuxi Chen; Peng Sun; Jianming Zhu; Qiang Zhang; Zhen Wang; Qiang Shao; Xiangrui Jiang; Bo Li; Kaixian Chen; Hualiang Jiang; Heyao Wang; Weiliang Zhu; Jingshan Shen
Journal:  ACS Med Chem Lett       Date:  2015-04-08       Impact factor: 4.345

2.  Synthesis and Pharmacochemistry of New Pleiotropic Pyrrolyl Derivatives.

Authors:  Markella Konstantinidou; Alice Gkermani; Dimitra Hadjipavlou-Litina
Journal:  Molecules       Date:  2015-09-10       Impact factor: 4.411

3.  Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19.

Authors:  Shahenda Mahgoub; Samar S Fatahala; Amira I Sayed; Hanaa B Atya; Mohamed F El-Shehry; Hala Afifi; Samir M Awad; Rania H Abd El-Hameed; Heba Taha
Journal:  Bioorg Chem       Date:  2022-08-10       Impact factor: 5.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.